Volume-targeted Versus Pressure-limited Noninvasive Ventilation in Patients With Acute Hypercapnic Respiratory Failure
1 other identifier
interventional
58
1 country
1
Brief Summary
Volume-targeted noninvasive ventilation (VT-NIV), a hybrid mode that targets a preseted tidal volume (VT) by automated adjustment of pressure support, could guarantee the delivered VT over pressure-limited noninvasive ventilation (PL-NIV) with fixed level pressure support. Whether VT-NIV is more effective in improving gas exchange in patients with acute hypercapnic respiratory failure (AHRF) as compared with PL-NIV remains unclear. Our aim was to verify whether in comparison with PL-NIV, use of VT-NIV was more effective in correcting hypercapnia, hence reducing the need for intubation and improving survival in patients with AHRF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 27, 2015
CompletedFirst Posted
Study publicly available on registry
September 2, 2015
CompletedMay 22, 2019
May 1, 2019
11 months
August 27, 2015
May 21, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
The decrease of arterial partial pressure of carbon dioxide (PaCO2) values from baseline to 6 hours after randomization
PaCO2 value at baseline minus PaCO2 value at 6 hours after randomization
6 hours after randomization
Study Arms (2)
Volume-targeted noninvasive ventilation
EXPERIMENTALFor Volume-targeted noninvasive ventilation, the target VT was set at 10 ml/kg of ideal body weight, with inspiratory positive airway pressure (IPAP) ranging from 10 cmH2O up to 25 cmH2O.
Pressure-limited noninvasive ventilation
NO INTERVENTIONFor Pressure-limited noninvasive ventilation, IPAP was initially set at 10 cmH2O, and was adjusted by increments of 1-2 cmH2O according to patients' tolerance (up to 25 cmH2O) to obtain a VT of 8-10 ml/kg of ideal body weight and a respiratory rate (RR) less than 25 breaths/min.
Interventions
Eligibility Criteria
You may qualify if:
- acute hypercapnic respiratory failure (AHRF)
- arterial pH \<7.35 and ≥7.25
- PaCO2 \>45 mmHg
You may not qualify if:
- age \<18 years
- excessive amount of respiratory secretions or weak cough
- upper airway obstruction
- recent oral, facial or cranial trauma or surgery
- recent gastric or esophageal surgery
- severe metabolic acidosis; severe abdominal distension
- cardiac or respiratory arrest
- PaO2/FiO2 \<150 mmHg
- pneumothorax
- severe ventricular arrhythmia or myocardial ischemia
- severe hemodynamic instability despite fluid repletion and use of vasoactive agents
- active upper gastrointestinal bleeding
- lack of cooperation
- refusal to receive NIV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Institute of Respiratory Medicine, Department of respiratory and critical care medicine, Beijing Chao-Yang Hospital Jingxi Campus, Capital Medical University
Beijing, China
Related Publications (1)
Cao Z, Luo Z, Hou A, Nie Q, Xie B, An X, Wan Z, Ye X, Xu Y, Chen X, Zhang H, Xu Z, Wang J, An F, Li P, Yu C, Liang Y, Zhang Y, Ma Y. Volume-Targeted Versus Pressure-Limited Noninvasive Ventilation in Subjects With Acute Hypercapnic Respiratory Failure: A Multicenter Randomized Controlled Trial. Respir Care. 2016 Nov;61(11):1440-1450. doi: 10.4187/respcare.04619. Epub 2016 Oct 18.
PMID: 27794079DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending physician
Study Record Dates
First Submitted
August 27, 2015
First Posted
September 2, 2015
Study Start
January 1, 2013
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
May 22, 2019
Record last verified: 2019-05